Network-based drug repurposing for HPV-associated cervical cancer

In women, cervical cancer (CC) is the fourth most common cancer around the world with average cases of 604,000 and 342,000 deaths per year. Approximately 50% of high-grade CC are attributed to human papillomavirus (HPV) types 16 and 18. Chances of CC in HPV-positive patients are 6 times more than HP...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Faheem, Yang, Young Jin, Samantasinghar, Anupama, Kim, Young Woo, Ko, Jeong Beom, Choi, Kyung Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618120/
https://www.ncbi.nlm.nih.gov/pubmed/37920815
http://dx.doi.org/10.1016/j.csbj.2023.10.038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618120/
https://www.ncbi.nlm.nih.gov/pubmed/37920815
http://dx.doi.org/10.1016/j.csbj.2023.10.038

Ejemplares similares